Sushentseva N N, Popov O S, Polkovnikova I A, Al'pako S V, Shcherbak S G
St. Petersburg City Hospital No. 40, Sestroretsk, Russia.
St. Petersburg State University, St. Petersburg, Russia.
Bull Exp Biol Med. 2022 May;173(1):133-138. doi: 10.1007/s10517-022-05508-0. Epub 2022 May 28.
We studied the differences in the characteristics of T-cell immunity in clinically healthy volunteers of three groups: "no previous COVID-19, not vaccinated", "recovered", and "vaccinated" as well as the relationship between the presence of IFNγ-releasing T cells in response to stimulation with peptide pools overlapping the main S, N, M, ORF3, and ORF7 protein sequences and the presence of IgG to the SARS-CoV-2 S protein. In the "no previous COVID-19, non-vaccinated" group, T cells specific to both S protein and other virus proteins were absent in 95% subjects. In the "recovered from COVID-19" group, T cells specific to the spike protein were present in samples from 39% subjects. In the same group, T-cell immunity to other viral proteins was present in 58% subjects. In vaccinated subjects, specific T cells responding to stimulation with S protein peptides were found in 47% cases and Т cells specific to N, M, ORF3, ORF7 proteins were detected in only 22% subjects.
我们研究了三组临床健康志愿者的T细胞免疫特征差异:“既往未感染过新冠病毒且未接种疫苗”组、“康复”组和“接种疫苗”组,以及在使用与主要S、N、M、ORF3和ORF7蛋白序列重叠的肽库刺激后,IFNγ释放T细胞的存在与针对SARS-CoV-2 S蛋白的IgG存在之间的关系。在“既往未感染过新冠病毒且未接种疫苗”组中,95%的受试者不存在针对S蛋白和其他病毒蛋白的特异性T细胞。在“新冠病毒康复”组中,39%受试者的样本中存在针对刺突蛋白的特异性T细胞。在同一组中,58%的受试者存在针对其他病毒蛋白的T细胞免疫。在接种疫苗的受试者中,47%的病例中发现了对S蛋白肽刺激有反应的特异性T细胞,而仅在22%的受试者中检测到针对N、M、ORF3、ORF7蛋白的特异性T细胞。